MEDP logo

MEDP

Medpace Holdings Inc.

$429.91
-$2.89(-0.67%)
47
Overall
50
Value
20
Tech
71
Quality
How is this score calculated?
Market Cap
$15.47B
Volume
147.70K
52W Range
$291.28 - $628.92
Target Price
$453.18

Company Overview

Mkt Cap$15.47BPrice$429.91
Volume147.70KChange-0.67%
P/E Ratio34.3Open$443.54
Revenue$2.5BPrev Close$432.80
Net Income$451.1M52W Range$291.28 - $628.92
Div YieldN/ATarget$453.18
Overall47Value50
Quality71Technical20

No chart data available

About Medpace Holdings Inc.

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.

Sector: Healthcare
Industry: Diagnostics & Research

Latest News

Medpace shareholders approve governance changes enhancing voting rights

The latest update is out from Medpace Holdings ( ($MEDP) ). At its May 15, 2026 annual meeting, Medpace Holdings, Inc. shareholders approved amendm...

TipRanks Auto-Generated Newsdesk7 days ago
ABCD
1SymbolPriceChangeVol
2MEDP$429.91-0.7%147.70K
3
4
5
6

Get Medpace Holdings Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.